Capricor Therapeutics's total assets for Q1 2025 were $153.77B, an increase of 90095.33% from the previous quarter. CAPR total liabilities were $3.78B for the fiscal quarter, a 15023.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.